Biodesix Inc
BDSX- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001439725
In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $1.03M in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +5 vs. previous quarter
- 45
- 13F valueReported value at the end of Q2 2026
- $98.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BDSX, Q2 2026
No superinvestor reported holding BDSX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Biodesix Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)5:22 PM ET | Aug 12 | 1 day | Schuler Jack W10% Owner, Other: Emeritus Director | PPurchase | +15.0K | $24.47 | +$367.0K | +2.8%555.8K after | |
| Aug 12, 2026 (view filing)5:55 PM ET | Aug 10-11 | 2 days | Schuler Jack W10% Owner, Other: Emeritus Director | PPurchase | +27.6K | $24.13 | +$665.9K | +5.4%540.8K after | 2 lots |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Vazquez ChrisChief Accounting Officer | SSale | −211 | $12.78 | −$2.70K | −11.7%1.59K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Cowie Robin HarperCFO, Sec'y & Treasurer | SSale | −535 | $12.78 | −$6.84K | −3.2%16.2K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Hutton ScottPresident & CEO | SSale | −1.49K | $12.78 | −$19.0K | −3.0%48.8K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Pestano Gary AnthonyChief Development Officer | SSale | −556 | $12.78 | −$7.11K | −5.1%10.4K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | O'Kane KieranChief Commercial Officer | SSale | −535 | $12.78 | −$6.84K | −5.2%9.82K after | |
| Feb 11, 2026 (view filing) | Feb 10 | 1 day | Cowie Robin HarperCFO, Sec'y & Treasurer | SSale | −941 | $10.08 | −$9.49K | −5.8%15.3K after | |
| Feb 11, 2026 (view filing) | Feb 10 | 1 day | Vazquez ChrisChief Accounting Officer | SSale | −101 | $10.08 | −$1.02K | −7.6%1.23K after | |
| Feb 11, 2026 (view filing) | Feb 10 | 1 day | O'Kane KieranChief Commercial Officer | SSale | −584 | $10.08 | −$5.89K | −6.2%8.88K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Biodesix Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 678,328 | $15.3M | 1.38% | −80,000−10.5% | Reduced |
| Soleus Capital Management, L.P. | 585,958 | $13.2M | 0.46% | +169,359+40.7% | Added |
| Telemark Asset Management, LLC | 489,824 | $11.0M | 0.80% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 388,639 | $8.76M | 0.01% | −69,799−15.2% | Reduced |
| Birchview Capital, LP | 286,804 | $6.47M | 3.02% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 284,169 | $6.41M | 0.00% | +29,008+11.4% | Added |
| Essex Investment Management Co LLC | 241,915 | $5.46M | 0.71% | +109,829+83.1% | Added |
| Opaleye Management Inc. | 180,000 | $4.06M | 0.37% | −58,047−24.4% | Reduced |
| Marshall Wace, LLP | 116,199 | $2.62M | 0.00% | −25,437−18.0% | Reduced |
| Perceptive Advisors LLC | 108,694 | $2.45M | 0.04% | +108,694 | New |